Microchips Biotech Information

Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our proprietary microchip-based implant can store and release precise doses of drugs at scheduled intervals for up to 16 years. The implant, which is placed under the skin by a trained physician during a simple office procedure using local anesthesia, can be wirelessly activated or deactivated by a physician or patient, without requiring removal. In addition, physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient. Our commercialization strategy is focused on using our implant to deliver established and currently-approved preventative and therapeutic agents that require frequent, critical or long-term dosing. Our lead product is a microchip-based formulation of a proven hormonal contraceptive designed to provide up to 16 years of reversible birth control to meet the evolving long-term family planning needs of women. In addition, we are exploring potential applications for the microchip platform in osteoporosis, multiple sclerosis and diabetes. Microchips was co-founded by renowned MIT researchers Robert Langer, PhD and Michael J. Cima, PhD, and is funded by leading healthcare and technology venture investors including Polaris Partners, Medtronic, InterSouth, Flybridge Capital and InterWest.